SERA
Sera Prognostics, Inc.
Save
Create a free account to get access to stock details and our dividend tracker
We won't send you any spam and we don't want a credit card.
136.00M
Market cap
–
Current P/E
–
Forward P/E
–
Dividend yield
About stock
Health Care
Sector
Health care
Industry
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression.
Similar stocks
Based on sector and market capitalization
Report issue